Porphyria Approved Drugs
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Porphyria.
Found 1 Approved Drug for Porphyria
Givlaari
Generic Name
Givosiran
Givlaari
Generic Name
Givosiran
Form: Injection
Method of administration: Subcutaneous
FDA approval date: December 12, 2019
Classification: Small Interfering RNA
GIVLAARI is indicated for the treatment of adults with acute hepatic porphyria (AHP). GIVLAARI is an aminolevulinate synthase 1-directed small interfering RNA indicated for the treatment of adults with acute hepatic porphyria (AHP). ( 1 )
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances